🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
GSK1278863 is an orally available, hypoxia-inducible factor - prolyl hydrox...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-02-17
Trial ID
NCT02689206
Treatments Being Tested
Absorption, metabolism and excretion of daprodustat (GSK1278863) have been ...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-10-10
Trial ID
NCT03239522
This study is intended to evaluate the dose-response relationship of GSK127...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-01
Trial ID
NCT01977482
Treatments Being Tested
This is a Phase III, open-label, active-controlled, parallel-group, multi-c...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-06
Trial ID
NCT02791763
Treatments Being Tested
The study will evaluate the ability of GSK1278863 to increase the hemoglobi...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-06-11
Trial ID
NCT02075463
Treatments Being Tested
The purpose of this study is to characterize the safety and tolerability of...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-12
Trial ID
NCT00935831
Treatments Being Tested
This study is being performed to comply with regulatory requirements that a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-17
Trial ID
NCT02293148